Yijia Group Corp. reported significant financial growth in its latest 10-K filing for the fiscal year ending April 30, 2025, with revenues reaching $2.66 million, a substantial increase of 366% from $570,694 in the previous fiscal year. The company's gross profit also saw a notable rise, climbing to $1.58 million from $377,711, driven primarily by the expansion of its healthcare products segment. The net income for the year was $850,746, compared to $140,865 in the prior year, reflecting a strong operational performance.
The company has undergone significant changes in its corporate structure and leadership. In June 2023, Barry Sytner, the major shareholder, sold approximately 86.3% of the company's shares to Xianchang Ma, who subsequently became the CEO. Following Ma's passing in August 2023, his heir, Caihong Qu, assumed control of the company. In September 2023, Qiuping Lu was appointed as the new CEO and CFO. Additionally, Yijia established a wholly-owned subsidiary, Nutripeak Trading Corporation, in November 2023, aimed at marketing and supplying healthcare products.
Operationally, Yijia Group has focused on expanding its customer base and product offerings. The healthcare segment, which includes anti-aging products, accounted for the majority of revenue, generating $2.65 million, while the consulting service segment contributed $10,838. The company reported a significant increase in customer engagement, particularly in Hong Kong and the United States, where revenues surged to $1.07 million and $1.20 million, respectively. The total number of employees remains low, with only one full-time employee reported, although additional personnel are ready to be hired as needed.
The filing also highlighted the company's strategic initiatives to navigate competitive pressures, including product innovation, flexible pricing strategies, and international market expansion. Yijia's management expressed optimism about future growth, citing ongoing efforts to enhance its product lines and explore new market opportunities. The company aims to leverage its recent capital raise of $957,051 from a private offering to support these initiatives and further solidify its market position.
Looking ahead, Yijia Group Corp. remains focused on its dual business model of consulting services and healthcare products. The management anticipates continued revenue growth driven by the healthcare segment, while also seeking to optimize operational efficiencies. However, the company acknowledges the inherent risks associated with its growth strategy, including market competition and the need for effective management of resources.
About YIJIA GROUP CORP.
Yijia Group Corp. is a Nevada-based company providing management, financial consulting, and healthcare products, including anti-aging NAD+ boosters and health consultations. It operates through two segments: consulting services and healthcare product sales. Serving domestic and international markets, it leverages multi-channel marketing, strategic alliances, and product innovation to deliver personalized wellness solutions and management advisory services.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.